ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
ALTE03N1: Key Adverse Events After Childhood Cancer
Protocol ID
ALTE03N1
Disease (Sub Disease)
Childhood Malignant Neoplasm
Diagnosis Stage
Previously treated
Location
QLD, WA, SA
Sponsor
Children's Oncology Group
Collaborators
National Cancer Institute (NCI)
Links
External Registry ≫
Trial Status
Open
Sites
Women's & Children's Hospital
Queensland Children's Hospital
Perth Children's Hospital
Study Type
Observational
Phase
Not applicable
Age Eligibility
up to 21 Years
International registry ID's
NCT00082745
Back to Registry
Study Title ALTE03N1: Key Adverse Events After Childhood Cancer
Protocol ID ALTE03N1
Disease (Sub Disease) Childhood Malignant Neoplasm
Diagnosis Stage Previously treated
Location QLD / WA / SA
Sponsor Children's Oncology Group
Collaborators National Cancer Institute (NCI)
Links https://clinicaltrials.gov/ct2/show/NCT00082745
Trial Status Open
Trial Open Date 24/03/2004
Sites Women's & Children's Hospital / Queensland Children's Hospital/ Perth Children's Hospital
Study Type Observational
Phase Not applicable
Age Eligibility up to 21 Years
International registry ID's NCT00082745

Join our newsletter

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Email info@anzchog.org   |  

Level 6, TRF Building, Hudson Institute, 27-31 Wright St, Clayton VIC 3168

ANZCHOG acknowledges Traditional Owners of Country throughout Australia and recognises the continuing connection to lands, waters and communities. We pay our respect to Aboriginal and Torres Strait Islander cultures, and to Elders both past and present. We acknowledge Māori as tangata whenua of Aotearoa New Zealand and as Treaty partners with the Crown as agreed in Te Tiriti o Waitangi. 

We are committed to creating a safe and welcoming environment that embraces all backgrounds, cultures, sexualities, genders and abilities.